Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yueh-Hsuan Chan"'
Autor:
Yi-An Ko, Yueh-Hsuan Chan, Chin-Hsiu Liu, Jian-Jong Liang, Tsung-Hsien Chuang, Yi-Ping Hsueh, Yi-Ling Lin, Kuo-I Lin
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Plasmacytoid dendritic cells (pDCs) are a specialized subset of DCs capable of rapidly producing copious amounts of type I IFN (IFN-I) in response to viral infections. The mechanism regulating rapid production of IFN-I after pDCs are exposed to viral
Externí odkaz:
https://doaj.org/article/15213e4698a54c2eba68d4f0a9bb875c
Autor:
Yueh-Hsuan Chan, 詹月瑄
98
Dendritic cells (DCs) are important for the initiation and regulation of immune responses. However, the molecular mechanisms that govern DC development are largely unclear. In this thesis, we show that the transcriptional repressor, B lymphoc
Dendritic cells (DCs) are important for the initiation and regulation of immune responses. However, the molecular mechanisms that govern DC development are largely unclear. In this thesis, we show that the transcriptional repressor, B lymphoc
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/49215815705745897217
Autor:
Yueh-Hsuan Chan, 詹月瑄
92
Osteoprotegerin (OPG), a member of tumor necrosis factor receptor superfamily, is a soluble receptor for both TRANCE and TRAIL. It is well known that OPG regulates bone metabolism by blocking the effects of TRANCE to inhibit osteoclast differ
Osteoprotegerin (OPG), a member of tumor necrosis factor receptor superfamily, is a soluble receptor for both TRANCE and TRAIL. It is well known that OPG regulates bone metabolism by blocking the effects of TRANCE to inhibit osteoclast differ
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/76564462654672517829
Publikováno v:
Pediatric Allergy and Immunology. 27:446-451
Targeting the IgE pathway is a clinically validated strategy for treating IgE-mediated diseases. Omalizumab, an anti-IgE antibody, which binds to free IgE and prevents the binding of IgE to FcεRI on mast cells and basophils has been approved for sev
Publikováno v:
Nature Communications. 5
IgE mediates hypersensitivity reactions responsible for most allergic diseases, which affect 20-40% of the population in developed countries. A 52-residue domain of membrane-bound IgE (mIgE) called CεmX is currently a target for developing therapeut
Autor:
Ming-Hsu Chen, Yueh-Hsuan Chan, Yueh-Chiao Tsai, Mau-Sheng Hou, Shin-Tang Su, Ming-Feng Chiang, Kuo-I Lin
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 183(11)
Dendritic cells (DCs) are important for the initiation and regulation of immune responses. In this study, we demonstrate that DC homeostatic development in peripheral lymphoid organs is negatively regulated by the transcriptional repressor, Blimp-1,
Developing an antibody targeting CεmX of mIgE for the treatment of IgE-mediated diseases (HYP4P.305)
Autor:
Yueh-Hsuan Chan, Yu-Tzu Lee, Hung-Wen Chou, Pheidias Wu, Jiun-Bo Chen, Chau-Hong Li, Tien-Tien Cheng, Nien-Yi Chen, Tse-Wen Chang, Ko-Haung Lue
Publikováno v:
The Journal of Immunology. 194:123.4-123.4
CεmX (also referred to as M1’) is a discrete domain of 52 a.a. residues, located between the CH4 domain and the C-terminal membrane anchor peptide of the ε heavy chain of membrane-bound IgE (mIgE) on human B lymphocytes. Antibodies that target C
Autor:
Yueh-Hsuan Chan, Yu-Tzu Lee, Hung-Wen Chou, Pheidias C Wu, Jiun-Bo Chen, Chau-Hong Li, Tien-Tien Cheng, Nien-Yi Chen, Ko-Haung Lue, Tse-Wen Chang
Publikováno v:
The Journal of Immunology. 192:140.15-140.15
CεmX (also referred to as M1’) is a discrete domain of 52 a.a. residues, located between the CH4 domain and the C-terminal membrane anchor peptide of the ε heavy chain of membrane-bound IgE (mIgE) on human B lymphocytes. Antibodies that target C
Publikováno v:
The Journal of Immunology. 190:59.3-59.3
CϵmX is a discrete domain of 52 a.a. residues, located between the CH4 domain and the C-terminal membrane anchor peptide of the ϵ heavy chain of membrane-bound IgE (mIgE) on human B cells. Among the monoclonal antibodies (mAbs) prepared for their a